Understanding the effects of RAF inhibitors on RAF signaling in B-RAF V600E mutant versus wild type tumors

被引:0
|
作者
Yen, Ivana
Song, Kyung
Stokoe, David
Brandhuber, Barbara
Gloor, Susan
Aliagas, Ignacio
Anderson, Daniel
Morales, Tony
Vigers, Guy
Ludlam, Mary
Alvarado, Ryan
Liu, Bonnie
Sideris, Steve
Ramaswamy, Sreema
Heise, Christopher
Belvin, Marcia
Friedman, Lou
Hatzivassiliou, Georgia
Malek, Shiva
机构
关键词
D O I
10.1158/1535-7163.TARG-09-B90
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B90
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Understanding the role of Raf signaling in B-Raf V600E mutant versus wildtype tumors
    Hatzivassiliou, G.
    Sideris, S.
    Yen, I.
    Gloor, S.
    Callejo, M.
    Brandhuber, B.
    Liu, B.
    Belvin, M.
    Malek, S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 183 - 184
  • [2] The inability of Spry2 to inhibit B-Raf V600E activity is required for induction of resistance to B-Raf inhibitor in B-Raf V600E cells
    Han, Byeal-I
    Ahn, Jun-Ho
    Jang, Gun-Hee
    Kim, Na-Yeon
    Lee, Michael
    FASEB JOURNAL, 2015, 29
  • [3] Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf
    Bandaru, Srinivas
    Sumithnath, Tharaparambil Gangadharan
    Sharda, Saphy
    Lakhotia, Sanskruti
    Sharma, Anudeep
    Jain, Amrita
    Hussain, Tajamul
    Nayarisseri, Anuraj
    Singh, Sanjeev Kumar
    CURRENT DRUG METABOLISM, 2017, 18 (06) : 527 - 534
  • [4] The mechanism of activation of monomeric B-Raf V600E
    Maloney, Ryan C.
    Zhang, Mingzhen
    Jang, Hyunbum
    Nussinov, Ruth
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 3349 - 3363
  • [5] Resistance to B-RAF inhibitor is mediated by reactivation of MAPK pathway by FGFR3/Ras signaling in B-RAF V600E mutant melanoma
    Yadav, Vipin
    Zhang, Xiaoyi
    Liu, Jiangang
    Estrem, Shawn
    Li, Shuyu Dan
    Gong, Xue-Qian
    Buchanan, Sean
    Henry, James R.
    Starling, James J.
    Peng, Sheng-Bin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [6] Discovery and optimization of a novel series of potent inhibitors of mutant (V600E) B-Raf kinase
    Vasbinder, Melissa
    Aquila, Brian
    Cook, Donald
    Drew, Lisa
    Fauber, Benjamin
    Grondine, Michael
    Hennessy, Edward
    Lyne, Paul
    Omer, Charles
    Palakurthi, Sangeetha
    Sha, Li
    Shen, Minhui
    Wang, Haixia
    Ye, Minwei
    CANCER RESEARCH, 2009, 69
  • [7] Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activity
    Lyne, Paul D.
    Aquila, Brian
    Cook, Donald J.
    Dakin, Les A.
    Ezhuthachan, Jay
    Ioannidis, Stephanos
    Pontz, Timothy
    Su, Mei
    Ye, Qing
    Zheng, Xiaolan
    Block, Michael H.
    Cowen, Scott
    Deegan, Tracy L.
    Lee, John W.
    Scott, David A.
    Custeau, Dominique
    Drew, Lisa
    Poondru, Srinivasu
    Shen, Minhui
    Wu, Allan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 1026 - 1029
  • [8] Novel natural inhibitors targeting B-RAF(V600E) by computational study
    Wu, Bo
    Zhang, Zhiyun
    Dou, Gaojing
    Lv, Xiaye
    Ge, Junliang
    Wang, Hongyu
    Xie, Haoqun
    Zhu, Dong
    BIOENGINEERED, 2021, 12 (01) : 2970 - 2983
  • [9] V600E B-Raf mutation is associated with chemoresistance in ovarian cancer
    Russo, Alessia E.
    Pellizzari, Ilenia
    Candido, Saverio
    Pezzino, Franca Maria
    Sorio, Roberto
    Baldassarre, Gustavo
    Canevari, Silvana
    McCubrey, James A.
    Libra, Massimo
    Scalisi, Aurora
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S68 - S68
  • [10] Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas
    Kondo, Tetsuo
    Nakazawa, Tadao
    Murata, Shin-ichi
    Kurebayashi, Junichi
    Ezzat, Shereen
    Asa, Sylvia L.
    Katoh, Ryohei
    HUMAN PATHOLOGY, 2007, 38 (12) : 1810 - 1818